Literature DB >> 11689043

A leucine zipper motif in the cytoplasmic domain of gp41 is required for HIV-1 replication and pathogenesis in vivo.

S M Kao1, E D Miller, L Su.   

Abstract

A leucine zipper motif is conserved in the cytoplasmic domain of glycoprotein gp41 (gp41c) of all HIV-1 subtypes, but is not present in HIV-2 or SIV. The second leucine residue of the leucine zipper was mutated (L95R) to determine the role of this motif in HIV-1 replication and pathogenesis. The L95R mutant replicated to wild-type levels in activated peripheral blood mononuclear cells and CEMx174 cells. However, L95R replication was impaired in SupT1 cells and in the SCID-hu Thy/Liv mouse. Although the infectivity of wild-type virions and that of L95R mutant virions were equally sensitive to heat treatment, we found that L95R produced more defective virions, due to reduced surface expression and virion incorporation of the env glycoprotein. These results suggest that the L95 residue in the leucine zipper of gp41c of HIV-1 plays an important role in the env expression and virion incorporation that is required for viral replication and pathogenesis in the SCID-hu Thy/Liv mouse. The leucine zipper motif in gp41c may provide a novel anti-HIV-1 target. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689043      PMCID: PMC4435951          DOI: 10.1006/viro.2001.1112

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Modulation of HIV-1 replication by a novel RhoA effector activity.

Authors:  L Wang; H Zhang; P A Solski; M J Hart; C J Der; L Su
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity.

Authors:  R W Buckheit; R Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  1991-03       Impact factor: 2.205

3.  Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

Authors:  M A Vodicka; W C Goh; L I Wu; M E Rogel; S R Bartz; V L Schweickart; C J Raport; M Emerman
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

4.  A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides.

Authors:  M A Miller; R F Garry; J M Jaynes; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1991-06       Impact factor: 2.205

5.  Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein.

Authors:  T P Beary; S B Tencza; T A Mietzner; R C Montelaro
Journal:  J Pept Res       Date:  1998-01

6.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

7.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

Authors:  D Schols; J A Esté; G Henson; E De Clercq
Journal:  Antiviral Res       Date:  1997-08       Impact factor: 5.970

9.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

10.  Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.

Authors:  S K Srinivas; R V Srinivas; G M Anantharamaiah; R W Compans; J P Segrest
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

View more
  5 in total

1.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.

Authors:  Vanessa Emerson; Denise Holtkotte; Tanya Pfeiffer; I-Hsuan Wang; Martina Schnölzer; Tore Kempf; Valerie Bosch
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

3.  Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission.

Authors:  Rajesh Ramakrishnan; Roshni Mehta; Vasudha Sundaravaradan; Tiffany Davis; Nafees Ahmad
Journal:  Retrovirology       Date:  2006-07-04       Impact factor: 4.602

4.  Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.

Authors:  Qi Wang; Lishan Su
Journal:  mBio       Date:  2019-08-20       Impact factor: 7.867

5.  HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.

Authors:  Alexis Kafando; Christine Martineau; Mohamed El-Far; Eric Fournier; Florence Doualla-Bell; Bouchra Serhir; Adama Kazienga; Mohamed Ndongo Sangaré; Mohamed Sylla; Annie Chamberland; Hugues Charest; Cécile L Tremblay
Journal:  Viruses       Date:  2019-11-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.